Gene · 5251
Papers1,921
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,921
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Whole exome sequencing identifies two novel variants in PHEX and DMP1 in Malaysian children with hypophosphatemic rickets. | Ital J Pediatr | 2022 | 36482408 | PubTator, text mining | PubMed |
| Identification of human progenitors of exhausted CD8+ T cells associated with elevated IFN-γ response in early phase of viral infection. | Nat Commun | 2022 | 36477661 | PubTator, text mining | PubMed |
| Why does the metabolic cost of walking increase on compliant substrates? | J R Soc Interface | 2022 | 36448287 | PubTator, text mining | PubMed |
| Determination of iFGF23 Upper Reference Limits (URL) in healthy pediatric population, for its better correct use. | Front Endocrinol (Lausanne) | 2022 | 36440231 | PubTator, text mining | PubMed |
| Perspectives on pediatric congenital aortic valve stenosis: Extracellular matrix proteins, post translational modifications, and proteomic strategies. | Front Cardiovasc Med | 2022 | 36439995 | PubTator, text mining | PubMed |
| CYP4 subfamily V member 2 (CYP4V2) polymorphisms were associated with ischemic stroke in Chinese Han population. | BMC Med Genomics | 2022 | 36437455 | PubTator, text mining | PubMed |
| Bioactivity Potential of Bioceramic-Based Root Canal Sealers: A Scoping Review. | Life (Basel) | 2022 | 36430988 | PubTator, text mining | PubMed |
| Effectiveness, implementation, and monitoring variables of intermittent hypoxic bicycle training in patients recovered from COVID-19: The AEROBICOVID study. | Front Physiol | 2022 | 36406995 | PubTator, text mining | PubMed |
| Current and Future Therapeutical Aspects of X-Linked Hypophosphatemia in Children With Special Attention to Klotho/Fibroblast Growth Factor 23 System. | J Clin Med Res | 2022 | 36406946 | PubTator, text mining | PubMed |
| Burosumab and Dental Abscesses in Children With X-Linked Hypophosphatemia. | JBMR Plus | 2022 | 36398111 | PubTator, text mining | PubMed |
| New treatments for rare bone diseases: hypophosphatemic rickets/osteomalacia. | Arch Endocrinol Metab | 2022 | 36382755 | PubTator, text mining | PubMed |
| Terminal repeats impact collagen triple-helix stability through hydrogen bonding. | Chem Sci | 2022 | 36382282 | PubTator, text mining | PubMed |
| Prospective Analysis of Muscle Adiposity in Children With X-linked Hypophosphatemic Rickets vs Control Children. | J Endocr Soc | 2022 | 36381011 | PubTator, text mining | PubMed |
| Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormone. | Orphanet J Rare Dis | 2022 | 36371259 | PubTator, text mining | PubMed |
| A Review of Current Evidence on the Relationship between Phosphate Metabolism and Metabolic Syndrome. | Nutrients | 2022 | 36364791 | PubTator, text mining | PubMed |
| On the Solution of Thermal Buckling Problem of Moderately Thick Laminated Conical Shells Containing Carbon Nanotube Originating Layers. | Materials (Basel) | 2022 | 36363024 | PubTator, text mining | PubMed |
| [FGF23 tumor induced osteomalacia]. | Probl Endokrinol (Mosk) | 2022 | 36337019 | PubTator, text mining | PubMed |
| Emerging therapies for the treatment of rare pediatric bone disorders. | Front Pediatr | 2022 | 36304528 | PubTator, text mining | PubMed |
| Establishment of inclusive single-cell transcriptome atlases from mouse and human tooth as powerful resource for dental research. | Front Cell Dev Biol | 2022 | 36299483 | PubTator, text mining | PubMed |
| The Impact of Job Stress, Role Ambiguity and Work-Life Imbalance on Turnover Intention during COVID-19: A Case Study of Frontline Health Workers in Saudi Arabia. | Int J Environ Res Public Health | 2022 | 36293713 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5251/papers?page=18